1h Free Analyst Time
The rabies treatment market is poised to grow by $1.06 billion during 2020-2024, progressing at a CAGR of 5% during the forecast period.Speak directly to the analyst to clarify any post sales queries you may have.
This report on the rabies treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment.
The market is driven by the need for contamination-free vaccines with novel culture media, the growing issue of stray animals in developing economies and novel routes of administration. In addition, the need for contamination-free vaccines with novel culture media is anticipated to boost the growth of the market as well.
The rabies treatment market analysis includes product segment, application segment, route of administration segment and geographical landscapes.
The rabies treatment market is segmented as below:
By Product
- Vaccines
- RIG
By Application
- Pre-exposure vaccination
- Post-exposure prophylaxis
By Route of Administration
- Intradermal route of administration
- Intramuscular route of administration
- Oral route of administration
By Geographical Landscapes
- Asia
- Europe
- North America
- ROW
This study identifies the growing awareness about animal health and welfare as one of the prime reasons driving the rabies treatment market growth during the next few years. Also, the zero human rabies by 2030 initiative and the introduction of monoclonal antibodies will lead to sizable demand in the market.
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
This report on the the rabies treatment market covers the following areas:
- Rabies treatment market sizing
- Rabies treatment market forecast
- Rabies treatment market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading rabies treatment market vendors that include Bavarian Nordic AS, Bharat Biotech Ltd., Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., Grifols SA, Kedrion Spa, Merck & Co. Inc., Sanofi, Serum Institute of India Pvt. Ltd., and Zoetis Inc. Also, the rabies treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.
The analyst's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Product
Market Segmentation by Application
Market Segmentation by Route of Administration
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibits
Executive Summary
The analyst recognizes the following companies as the key players in the global rabies treatment market: Bavarian Nordic AS, Bharat Biotech Ltd., Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., Grifols SA, Kedrion Spa, Merck & Co. Inc., Sanofi, Serum Institute of India Pvt. Ltd., and Zoetis Inc.According to one of the team's analysts: The latest trend gaining momentum in the market is growing awareness about animal health and welfare.
According to the report, one of the major drivers for this market is the need for contamination-free vaccines with novel culture media.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bavarian Nordic AS
- Bharat Biotech Ltd.
- Boehringer Ingelheim International GmbH
- Elanco Animal Health Inc.
- Grifols SA
- Kedrion Spa
- Merck & Co. Inc.
- Sanofi
- Serum Institute of India Pvt. Ltd.
- Zoetis Inc.
